Global PARP Inhibitor Biomarkers Testing Product Market Share Forecast to 2034
The growing adoption of precision oncology is transforming cancer diagnostics and treatment pathways across healthcare systems worldwide. Biomarker testing products designed to identify patients eligible for PARP inhibitor therapies are becoming increasingly important as personalized medicine gains momentum. Rising cancer … Read more